Rpharmy Overhauls BlackboxRX User Experience, Interface
Rpharmy, a leading provider of medical formulary management and hazardous drug safety information software solutions, today announced a significant upgrade to the user experience (UX) of its BlackboxRX solution, the only online comprehensive database of medication boxed safety warnings. As part of an extensive UX upgrade to all Rpharmy solutions, BlackboxRX is the first to undergo the in-depth enhancement to its form and function.
"Twenty years ago, we introduced BlackboxRX in response to a customer's critical need for managing black box warnings. Recognized consistently as a trusted source for essential drug safety information, we believed it was crucial to modernize its aesthetic and usability to better serve today's healthcare professionals," said Laura Paxton, Rpharmy CEO and Founder. "The upgraded BlackboxRX features a completely redesigned interface that's intuitive to use, a more efficient search process, and new functionalities that empower healthcare providers to access crucial drug safety information instantly and effortlessly."
BlackboxRX has undergone a comprehensive redesign featuring the following innovations to user experience:
Simplified Discovery: Easily locate drugs by therapeutic class via a new, prominently placed link on the BlackboxRX homepage.
Expanded Safety Information: Selecting a drug now provides users with enriched safety information, including accessible links to essential resources like patient counseling aids, REMS, package inserts, and critical FDA drug safety updates.
Enhanced Search Capabilities: The BlackboxRX search bar now features intelligent auto-fill capabilities. As users type a drug name, all related instances dynamically populate, offering seamless navigation either through specific warning information or by therapeutic class.
New Homepage Resources: The new BlackboxRX homepage now prominently displays the most recent drug warnings along with their publication dates. Additionally, users can easily access a list of the top five most frequently viewed warnings, keeping healthcare professionals informed of the most critical and sought-after safety information.
Rpharmy's hazardous drug safety platform, Rhazdrugs, and the medication safety database, Formweb, are also undergoing a user experience redesign. The new versions of the SaaS solutions will be available later in 2024.
About Rpharmy
For more than 30 years, Rpharmy has been solving problems related to medication safety and patient care. We develop and provide technology focused on medical formulary, hazardous drug handling, and HFAP, NIOSH and Joint Commission compliance. Our primary desire is to keep all patients and healthcare workers safe through easy access to critical medication safety information. For more information, visit https://www.rpharmy.com/
Garrett Smith, Founder and CEO of Community Capital Technology Inc. ("Community Capital"), will be attending the Milken Institute Global Conference ("MI Global") May 5-8, 2024 in Los Angeles. The event brings together global executives and...
Quarterhill Inc. ("Quarterhill" or the "Company") , a leading provider of tolling and enforcement solutions in the Intelligent Transportation System ("ITS")...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from the first and largest real-world patient cohort review...
Smart Meter, the leading supplier of Cellular Remote Patient Monitoring (RPM)tm solutions, has introduced a new version of the iGlucose, its patented cellular-connected glucose meter used by over 200,000 people with diabetes since 2019. The...
F5 announced that it has been singled out as a visionary in API security for its F5 Distributed Cloud Web App and API Protection (WAAP) in Enterprise Management Associates' Vendor Vision 2024 report. The report highlights "must see" security...
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...